Title:
骨髄腫を治療するためのセルデュラチニブ（ＣＥＲＤＵＬＡＴＩＮＩＢ）
Document Type and Number:
Japanese Patent JP6833816
Kind Code:
B2
Abstract:
Compositions and methods for treating multiple myeloma (MM), acute myeloid lymphoma (AML) or a myeloproliferative disease (MPD) in a human patient in need thereof. The methods entail administering to the patient an effective amount of cerdulatinib.
Inventors:
Coffey, Gregory
Fen, Jaja
Fen, Jaja
Application Number:
JP2018506528A
Publication Date:
February 24, 2021
Filing Date:
August 12, 2016
Export Citation:
Assignee:
Portra Pharmaceuticals, Inc.
International Classes:
A61K31/506; A61K31/17; A61K31/198; A61K31/282; A61K31/454; A61K31/475; A61K31/519; A61K31/573; A61K31/675; A61K31/69; A61K31/704; A61K31/7048; A61K33/243; A61K45/00; A61P35/00; A61P43/00
Domestic Patent References:
| JP2011518157A |
Foreign References:
| US20140031361 |
Other References:
Blood,2014年,Vol.124, No.21,Poster No.3103, p.1-3,URL,https://doi.org/10.1182/blood.V124.21.3103.3103
Journal of Pharmacology and Experimental Therapeutics,2014年,Vol.351,p.538-548
Journal of Pharmacology and Experimental Therapeutics,2014年,Vol.351,p.538-548
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita
Previous Patent: 共有無線周波数スペクトル帯域および専用無線周波数スペクトル帯域中の...
Next Patent: 量子装置間の高次相互作用を生成および使用するためのシステムおよび方...
Next Patent: 量子装置間の高次相互作用を生成および使用するためのシステムおよび方...